- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr David Blumenthal Looks Back as The Commonwealth Fund Celebrates 100 Years
As The Commonwealth Fund celebrates 100 years, David Blumenthal, MD, MPP, looks back at the work it has done.
As The Commonwealth Fund celebrates 100 years, David Blumenthal, MD, MPP, looks back at the work it has done.
Transcript
This year, the Commonwealth Fund is celebrating their 100th year, and you have launched a website in commemoration. How has the organization worked to improve healthcare over the years?
Well, we have over the last 100 years we’ve been committed to improving the health of the American people as well as working on international issues and to improving the care, especially of vulnerable populations. Some of the things we’ve done over the years, we were among the original supporters of the Pap Smear. We’ve also helped fund rural hospitals in the south and that led to the program called the Hillburton Act which funded hospitals throughout the United States in the 40s and 50s. We were the first supporter of hospice in the United States, we funded a demonstration at Yale, and we were early on in supporting the development of health maintenance organizations. We were early funders of Harvard community health plan in Boston which was one of the first successful plans outside of the Kaiser pre-paid group pay practice model.
To visit the Commonwealth Fund's centennial website, click here.
Has the Commonwealth Fund done work internationally?
The Commonwealth Fund has also done a lot of international work and that’s becoming more interesting now to people in this particular time. We’re very proud of the fact that we have constantly demonstrated the alternatives and the availability of alternatives to the way we deliver care in the United States and we are continuing to do that. We believe that we have the best information available on alternative approaches to healthcare based on the other countries that we study intensively.
The Push for Fair Pricing and Reform in Pharmacy Benefit Management
April 3rd 2025Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving healthcare landscape.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Using AI-Driven Strategies to Optimize Specialty Drug Costs, Manage Polypharmacy
April 2nd 2025As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for managing specialty drug spending and polypharmacy risks, as showcased in recent research presented at the Academy of Managed Care Pharmacy 2025 conference.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
How Recent Federal Policy Changes Are Shaping Managed Care Pharmacy
April 2nd 2025Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, pharmacy benefit manager reform, and health care policy shifts—topics explored by experts at the Academy of Managed Care Pharmacy's annual meeting.
Read More
The IRA’s Unintended Consequences for Drug Pricing and Coverage
April 2nd 2025The Inflation Reduction Act (IRA) may be restricting Medicare Part D formularies, increasing patient costs, and stifling pharmaceutical innovation, experts warned at the Academy of Managed Care Pharmacy 2025 annual meeting.
Read More
